Agenus宣布BOT+BAL联合免疫疗法用于MSS或pMMR转移性结直肠癌的全球3期BATTMAN试验完成首例患者入组
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in